US EditionA memorandum of understanding was signed with the Chinguetti Pharma Group: Saidal will begin exporting its products to Mauritania.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
The pharmaceutical company Saidal signed a commercial memorandum of understanding with the Mauritanian group Chinguitty Pharma on Thursday in Algiers to supply Mauritania with Algerian medicines. The agreement was initialed by Saidal's acting CEO, Ms. Soraya Sebbah, and the Mauritanian group's Managing Director, Mr. Amar Mohamed Najem, during a ceremony chaired by the Minister of Pharmaceutical Industry, Mr. Ouacim Kouidri. On this occasion, the…
The Algerian pharmaceutical group Saidal signed a commercial memorandum of understanding with the Mauritanian group Chinguetti Pharma, aiming to strengthen cooperation between the two parties in several areas, particularly in supplying and promoting the Mauritanian market with Algerian medicines. The agreement was signed today, Thursday, April 24, in Algiers, by the acting CEO of Saidal, Soraya Sabah, and the CEO of the Mauritanian group active …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
